Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J5UC
|
||||
| Former ID |
DIB016671
|
||||
| Drug Name |
SDZ-ISQ-844
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Asthma [ICD10:J45] | Terminated | [1] | ||
| Company |
Novartis AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H23NO5
|
||||
| Canonical SMILES |
C1(=N[C@@H](Cc2c1cc(c(c2)OC)OC)CO)c1cc(cc(c1)OC)OC
|
||||
| CAS Number |
CAS 143526-87-8
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Phosphodiesterase (PDE) 3 | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005292) | ||||
| REF 2 | Effects of inhaled SDZ ISQ 844, a cyclic nucleotide phosphodiesterase isoenzyme type III/IV inhibitor, on airway responsiveness in beagles. Arerugi. 1994 Apr;43(4):551-6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.